Alligator Bioscience AB (0RK9) Stock Statistics & Valuation Metrics

Alligator Bioscience AB has a market cap or net worth of kr155.92M. The enterprise value is kr1.06B.

Alligator Bioscience AB has 34,803,898 shares outstanding. The number of shares has decreased by -2.65% in one year.

Alligator Bioscience AB’s return on equity (ROE) is 1.79 and return on invested capital (ROIC) is 263.33%.

The current PE Ratio of Alligator Bioscience AB is -9.25. Alligator Bioscience AB’s PEG ratio is -0.15.

In the last 12 months, Alligator Bioscience AB had revenue of 57.77M and earned -233.89M in profits. Earnings per share was -26.93.

In the last 12 months, operating cash flow was -186.43M and capital expenditures -1.46M, giving a free cash flow of -187.89M billion.

Alligator Bioscience AB pays an annual dividend of ―, resulting in a dividend yield of ―

Alligator Bioscience AB upcoming earnings date is Jul 10, 2025, TBA Not Confirmed.

Alligator Bioscience AB as a current ratio of 0.35, with Debt / Equity ratio of 6.60%

In the past 12 months, Alligator Bioscience AB has paid 0.00 in taxes.

Alligator Bioscience AB EV to EBITDA ratio is -12.94, with an EV/FCF ratio of -10.08.

Alligator Bioscience AB has kr28.85M in cash and marketable securities with kr41.86M in debt, giving a net cash position of kr13.01M billion.

Gross margin is -3235.82%, with operating margin of -396.66%, and net profit margin of -404.89%.

The average price target for Alligator Bioscience AB is ―, which is 11.43% higher than the current price. The consensus rating is ―